Delivery Order 36F79718D0414-36C77021N0219
Award Date
9/10/21
Potential Completion Date
9/15/21
Potential Value
$675K
Funding Federal Agency
Veterans Integrated Service Network 12
Contracting Federal Agency
Veterans Integrated Service Network 15
Awardee
Neurocrine Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc. a $608,584.32 firm fixed price delivery order against the company's GSA Schedule Pharmaceuticals and Drugs contract. The delivery order, which runs from August 25-27, 2020, is for the drug valbenazine and will support the VA-VHA's Veterans Integrated Service Network 12 located in San Diego, California. Valbenazine is used to treat tardive dyskinesia, an involuntary movement disorder...
The Department of Veterans Affairs Veterans Health Administration awarded a $677,821.50 delivery order against the Pharmaceuticals and Drugs GSA Schedule to Neurocrine Biosciences, Inc. for the provision of valbenazine 40mg and 80mg oral capsules to the Hines VA Medical Center in Illinois. Valbenazine is used to treat tardive dyskinesia, an involuntary movement disorder associated with long-term use of certain medications. As the prime contractor, Neurocrine Biosciences will supply the...
The Department of Veterans Affairs Veterans Health Administration awarded a $650,708 delivery order against the Pharmaceuticals and Drugs GSA Schedule to Neurocrine Biosciences, Inc. for the provision of valbenazine for the Hines VA Medical Center in Illinois. Valbenazine is used to treat tardive dyskinesia, an involuntary movement disorder that is a potential side effect of some medications prescribed for mental illness. The firm fixed price order runs from January 7-12, 2021 and will be...
The Department of Veterans Affairs Veterans Health Administration awarded a $676,204.80 firm fixed price delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide valbenazine to Veterans Integrated Service Network 12 in support of the VA-VHA's healthcare programs. Performance will take place in San Diego, California over a period of four days from October 8-12, 2020. No subcontractors or set...
The Department of Veterans Affairs Veterans Health Administration awarded a $576,116 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Neurocrine Biosciences, Inc. to provide valbenazine. The contract has a period of performance from March 26, 2020 through April 1, 2020 for product delivery to a location in San Diego, California. Valbenazine will support the VA-VHA's mission to provide healthcare services to veterans through its Veterans Integrated Service Network...
The Department of Veterans Affairs Veterans Health Administration awarded a $652,377.60 firm fixed price delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide valbenazine to Veterans Integrated Service Network 12 in support of the VA's efforts to serve veterans in the San Diego area. Valbenazine will be delivered to facilities located in San Diego, California over a one week period in...
The Department of Veterans Affairs Veterans Health Administration awarded a $677,546 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule to Neurocrine Biosciences, Inc. to provide valbenazine for Veterans Integrated Service Network 12. Valbenazine will be delivered to support VA-VHA programs in San Diego, California between June 23 and June 30, 2020. No subcontractors or set aside designations were identified. This order enables the VA medical center in San Diego...
The Department of Veterans Affairs Veterans Health Administration awarded a $536,349 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order calls for Neurocrine to provide the drug valbenazine to VHA facilities in San Diego, California from February 27 to March 3, 2020. Valbenazine will support VHA's efforts to treat veterans through its Veterans Integrated Service Network 12 program. As a firm fixed price order placed...
The Department of Veterans Affairs Veterans Health Administration awarded a $652,376 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order calls for the delivery of VALBENAZINE 80MG capsules to the Hines VA Medical Center in Illinois. The one-week period of performance from November 3 to November 10, 2020 indicates this was likely an urgent order to treat veterans for a condition addressed by the medication. Neurocrine...
The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc., a biopharmaceutical company, a delivery order contract worth $403,531.20 for the provision of VALBENAZINE 40mg and 80mg oral capsules. The contract was issued against Neurocrine's listing on the General Services Administration's Pharmaceuticals and Drugs schedule contract under the Multiple Award Schedule program. The contract had no set-aside designation and did not specify any...